ArticleFrontiers in microbiology2025
2,4-Di-tert-butylphenol from Endophytic Fungi
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Unraveling the anthelmintic efficacy of Curcuma amada Roxb. extract: A multi-modal mechanistic study against Raillietina spp. infection.Scientific reports · 2026Article
- Genome and Secondary Metabolites Analysis ofJournal of fungi (Basel, Switzerland) · 2026Article
- The endophyteFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The continuous emergence of drug-resistant pathogenic bacteria highlights the persistent importance of discovering and developing new antibiotics. Endophytic species are an infinite source of several medicinally essential secondary metabolites. Methods: The current study focuses on isolating secondary metabolites from the endophytic Results and discussion: Bioactivity-guided extraction of ethyl acetate fungal extract purification yielded a lead compound, 2,4-di-tert-butylphenol (DTB), which was interpreted by combining
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.